Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07233070 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 208 to confirmed 210 · Site details revised at 2 of 2 sitesv3 Show 2 more changesShow less
    • Enrollment target: estimated 208 to confirmed 210
    • Site details revised at 2 of 2 sites
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 2025 to Oct 31, 2025 · Site details revised at 2 of 2 sitesv2 Show 2 more changesShow less
    • Start date changed from estimate of Dec 2025 to Oct 31, 2025
    • Site details revised at 2 of 2 sites
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.
Trial Details
NCT Number NCT07233070
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Acute Ischemic Stroke
Enrollment 210 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov